Ingevity Co. (NYSE:NGVT) Shares Purchased by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its stake in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 57.6% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,854,554 shares of the company's stock after purchasing an additional 677,718 shares during the quarter. Victory Capital Management Inc. owned about 5.12% of Ingevity worth $87,572,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in NGVT. Dakota Wealth Management increased its stake in Ingevity by 36.7% in the 3rd quarter. Dakota Wealth Management now owns 5,301 shares of the company's stock valued at $252,000 after purchasing an additional 1,422 shares in the last quarter. Raymond James & Associates boosted its position in Ingevity by 1.1% during the third quarter. Raymond James & Associates now owns 46,519 shares of the company's stock worth $2,215,000 after purchasing an additional 516 shares in the last quarter. Brown Advisory Inc. boosted its position in Ingevity by 2.8% during the third quarter. Brown Advisory Inc. now owns 741,755 shares of the company's stock worth $35,315,000 after purchasing an additional 20,376 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in Ingevity by 15.9% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,733 shares of the company's stock worth $368,000 after purchasing an additional 1,061 shares in the last quarter. Finally, Inspire Investing LLC boosted its position in Ingevity by 20.5% during the third quarter. Inspire Investing LLC now owns 6,475 shares of the company's stock worth $308,000 after purchasing an additional 1,101 shares in the last quarter. Hedge funds and other institutional investors own 91.59% of the company's stock.

Analyst Upgrades and Downgrades

NGVT has been the topic of a number of research analyst reports. Oppenheimer boosted their target price on Ingevity from $50.00 to $58.00 and gave the stock an "outperform" rating in a research report on Thursday. Jefferies Financial Group upgraded Ingevity from a "hold" rating to a "buy" rating and boosted their target price for the stock from $52.00 to $62.00 in a research report on Monday, April 22nd. Finally, Wells Fargo & Company boosted their target price on Ingevity from $43.00 to $50.00 and gave the stock an "equal weight" rating in a research report on Friday, February 23rd. Five equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $52.50.

Ingevity Price Performance

Shares of NYSE:NGVT traded down $1.24 on Friday, hitting $53.56. The company had a trading volume of 374,454 shares, compared to its average volume of 221,028. The company has a current ratio of 1.90, a quick ratio of 0.96 and a debt-to-equity ratio of 2.48. Ingevity Co. has a 52-week low of $36.66 and a 52-week high of $68.11. The business has a 50 day moving average of $46.99 and a 200 day moving average of $44.17. The company has a market cap of $1.94 billion, a PE ratio of -17.22 and a beta of 1.79.

Ingevity (NYSE:NGVT - Get Free Report) last released its earnings results on Wednesday, May 1st. The company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.37 by $0.15. The firm had revenue of $340.10 million during the quarter, compared to analyst estimates of $319.15 million. Ingevity had a positive return on equity of 18.65% and a negative net margin of 6.84%. The business's quarterly revenue was down 13.4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.09 earnings per share. As a group, equities analysts anticipate that Ingevity Co. will post 3.69 earnings per share for the current fiscal year.

Ingevity Company Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.